ＴＲＥＭ２安定化抗体

Title:

ＴＲＥＭ２安定化抗体

Document Type and Number:

Japanese Patent JP7342119

Kind Code:

B2

Abstract:

The present invention provides antibodies that bind to and stabilize human Triggering Receptor Expressed on Myeloid cells 2 (TREM2) protein and methods of using these antibodies.

More Like This:

JP2021052776	DNA ANTIBODY CONSTRUCTS AND METHOD OF USING THE SAME
JP7340638	MHC-E restricted epitopes, binding molecules and related methods and uses
JP6559607	New immunoconjugate

Inventors:

Brand, Verena
Feuerbach, Dominique
Gasparini, Fabricio
George, Natalie
Shuts, Everin
Simshek, Delaya
Shrinivas, Honappa
Wald Huber, Marks
Wilken, Reiner

Application Number:

JP2021520099A

Publication Date:

September 11, 2023

Filing Date:

October 15, 2019

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Novartis Age

International Classes:

C12N15/13; A61K31/7088; A61K35/12; A61K35/76; A61K39/395; A61K48/00; A61P9/00; A61P21/00; A61P25/00; A61P25/08; A61P25/16; A61P25/28; A61P27/02; A61P43/00; C07K16/28; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12N15/63; C12P21/08

Domestic Patent References:

JP2017523814A

Attorney, Agent or Firm:

Hiroshi Kobayashi
Eiji Katayama
Norio Omori
Emiko Nishizawa

Previous Patent: Video signal processing method and apparatus using multi-hypothesis prediction

Next Patent: Learning device, method and program, classification device, method and program, and trained model